Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Metrics Contract Services Unveils New Commercial Production Suites and Equipment

Metrics Contract Services (Metrics), a full-service global contract development and manufacturing organization (CDMO), has expanded its novel oral solid dose commercial facility in Greenville, North Carolina, adding 3,760 square feet of production space and new equipment. The expansion completes a...

Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company and Canadian biotech firm SaNOtize Research & Development Corp. announced an exclusive long term strategic partnership to manufacture, market and distribute its breakthrough Nitric Oxide Nasal Spray (NONS) for COVID-19 treatment...

Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine (mRNA-1345)

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA as granted Fast Track designation for mRNA-1345, its investigational single-dose mRNA vaccine against respiratory syncytial virus (RSV) in adults older than 60...

DisperSol and Catalent Collaborate to Establish KinetiSol Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline

DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Ashfield Health Launches Health Intelligence Platform, GRAVITYai

Ashfield Health, a global healthcare marketing and communications network and part of UDG Healthcare, has launched Gravity.ai, a global healthcare intelligence data platform. The data solution is designed to support pharma, life science, biotech, and other healthcare partners to...

GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment, sotrovimab

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an investigational single dose SARS-CoV-2 monoclonal antibody for the treatment of adults and...

Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19

Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. announced that U.S. based Adagio Therapeutics has granted an exclusive license to Biocon Biologics to manufacture and commercialize an antibody treatment based on ADG20 for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »